17 June 1988
COMMERCIAL ITEM DESCRIPTION
AMIKACIN SULFATE INJECTION, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be Amikacin Sulfate Injection, USP.
Shall be in accordance with the requirements of the USP.
Material used in manufacture shall be of pharmaceutical grade.
Shall contain the equivalent of 250 mg of Amikacin per ml, within the applicable assay limits.
Workmanship. The injection shall be free from defects which detract from their appearance or impair their serviceability.
For Size 1 – Package (PG). Shall be supplied 2 ml in a vial. One package containing 10 vials, as specified, constitutes one unit.
For Size 2 – Package (PG). Shall be supplied 4 ml in a vial. One package containing 10 vials, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business